FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
3,327 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-111 | 73648-0111-01 | — |
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-112 | 73648-0112-02 | — |
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-113 | 73648-0113-03 | — |
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-114 | 73648-0114-01 | — |
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-115 | 73648-0115-02 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-116 | 73648-0116-03 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-117 | 73648-0117-04 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-118 | 73648-0118-02 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-119 | 73648-0119-03 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-120 | 73648-0120-04 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-121 | 73648-0121-05 | — |
|---|
| Ryoncilremestemcel-l-rknd | — | Kit | Mesoblast | BLA | 73648-122 | 73648-0122-03 | — |
|---|
| Ryplazimplasminogen | Plasminogen 68.8 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Kedrion Biopharma, Inc. | BLA | 70573-099 | 70573-0099-02 | — |
|---|
| Ryshi SPF 50 Sunscreenavobenzone 3%, homosalate 15%, octisalate 5%, octocrylene 10% | Avobenzone 3 g/100g + 2 more ingredients | StickTopical | Rite Aid | OTC monograph drug | 11822-3115 | 11822-3115-01 | — |
|---|
| Rystiggorozanolixizumab | Rozanolixizumab 140 mg/mL | Injection, SolutionSubcutaneous | UCB, Inc. | BLA | 50474-980 | 50474-0980-79 | — |
|---|
| Rystiggorozanolixizumab | Rozanolixizumab 140 mg/mL | Injection, SolutionSubcutaneous | UCB, Inc. | BLA | 50474-981 | 50474-0981-83 | — |
|---|
| Rystiggorozanolixizumab | Rozanolixizumab 140 mg/mL | Injection, SolutionSubcutaneous | UCB, Inc. | BLA | 50474-982 | 50474-0982-84 | — |
|---|
| Rystiggorozanolixizumab | Rozanolixizumab 140 mg/mL | Injection, SolutionSubcutaneous | UCB, Inc. | BLA | 50474-983 | 50474-0983-86 | — |
|---|
| Rytarycarbidopa and levodopa | Levodopa 95 mg/1; Carbidopa hydrate 23.75 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | NDA | 64896-661 | 64896-0661-0164896-0661-0964896-0661-43+1 more | — |
|---|
| Rytarycarbidopa and levodopa | Levodopa 145 mg/1; Carbidopa hydrate 36.25 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | NDA | 64896-662 | 64896-0662-0164896-0662-0964896-0662-43+1 more | — |
|---|
| Rytarycarbidopa and levodopa | Levodopa 195 mg/1; Carbidopa hydrate 48.75 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | NDA | 64896-663 | 64896-0663-0164896-0663-0964896-0663-43+1 more | — |
|---|
| Rytarycarbidopa and levodopa | Levodopa 245 mg/1; Carbidopa hydrate 61.25 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals LLC | NDA | 64896-664 | 64896-0664-0164896-0664-43 | — |
|---|
| Ryteloimetelstat sodium | Imetelstat sodium 188 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Geron Corporation | NDA | 82959-111 | 82959-0111-01 | — |
|---|
| Ryteloimetelstat sodium | Imetelstat sodium 47 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | Geron Corporation | NDA | 82959-112 | 82959-0112-01 | — |
|---|
| RyVentcarbinoxamine maleate | Carbinoxamine maleate 6 mg/1 | TabletOral | Carwin Pharmaceutical Associates, LLC | ANDA | 15370-130 | 15370-0130-0215370-0130-10 | — |
|---|
| Ryzneutaefbemalenograstim alfa-vuxw | Efbemalenograstim alfa 20 mg/mL | InjectionSubcutaneous | Acrotech Biopharma Inc | BLA | 72893-016 | 72893-0016-02 | — |
|---|
| Ryzumviphentolamine mesylate | Phentolamine mesylate 10 mg/mL | Solution/ dropsOphthalmic | Oyster Point Pharma, Inc. | NDA | 83368-075 | 83368-0075-3083368-0075-31 | — |
|---|